浙江莎普爱思药业股份有限公司关于召开2025年三季度业绩说明会的公告

Core Viewpoint - Zhejiang Shapuaisi Pharmaceutical Co., Ltd. is set to hold a Q3 2025 performance briefing on November 18, 2025, to enhance investor understanding of its operational performance and development strategy [3][4]. Group 1: Meeting Details - The performance briefing will take place on November 18, 2025, from 15:30 to 16:30 [4]. - The meeting will be conducted online via the "Value Online" platform [4]. - Key personnel attending the meeting include Chairman Lin Hongli, Independent Director Chen Shengqun, CFO Lin Xiusong, and Board Secretary Huang Mingxiong [4]. Group 2: Investor Participation - Investors can submit questions before the meeting until November 18, 2025, through a designated website or by scanning a QR code [2][5]. - During the briefing, the company will address common investor concerns within the scope of information disclosure [2][5]. Group 3: Contact Information - For inquiries, investors can contact Huang Mingxiong or Wang Yu via phone, fax, or email [6].